Medical Devices Japan

Japan Proton Therapy Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Japan Proton Therapy Market Industry Trends and Forecast to 2034: Segmented by (Product, System, Cancer, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Japan · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $84.8 Mn Placeholder estimate
Estimate 2025 $92.7 Mn 6.5% of the global market
Projected 2034 $206.4 Mn 122.6% Adds $113.7 Mn over 9 forecast years
CAGR 2025–2034 9.3% Faster than 51% of 173 Medical Devices markets here
Key players 5
  • Japan is 6.5% of the global market.
  • In APAC, the largest is China at $117.0 Mn.
  • Fastest growing: India at 11.9% a year.
  • Japan ranks 2nd of 10 by size in APAC.

Market size projection

Japan

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$113.7 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Proton Therapy Market market size by year, Japan
YearMarket sizeChange that yearSince 2025
2024 (estimate) $84.8 Mn — —
2025 (base) $92.7 Mn +$7.9 Mn —
2026 (forecast) $101.3 Mn +$8.6 Mn +9.3%
2027 (forecast) $110.7 Mn +$9.4 Mn +19.5%
2028 (forecast) $121.0 Mn +$10.3 Mn +30.6%
2029 (forecast) $132.3 Mn +$11.3 Mn +42.7%
2030 (forecast) $144.6 Mn +$12.3 Mn +56%
2031 (forecast) $158.1 Mn +$13.4 Mn +70.5%
2032 (forecast) $172.8 Mn +$14.7 Mn +86.4%
2033 (forecast) $188.8 Mn +$16.1 Mn +103.7%
2034 (forecast) $206.4 Mn +$17.6 Mn +122.6%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Japan Proton Therapy Market Analysis at a glance
Market size, 2025$92.7 Mn placeholder estimate
Forecast, 2034$206.4 Mn placeholder estimate
Growth (CAGR), 2025–20349.3% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, system, cancer and end user (see all)
Key playersIBA (Ion Beam Applications), Varian (Siemens Healthineers), Hitachi Medical Systems, Mevion Medical Systems, Sumitomo Heavy Industries (see all)
Regulator in JapanPMDASource: Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Japan Proton Therapy Market Analysis Executive Summary

Proton therapy is a type of radiation therapy that uses protons to target tumours more precisely and spare healthy tissue.

Key segments of the proton Therapy market include product (Proton Therapy Systems and Services), system (Single-Room Systems and Multi-Room Systems) and cancer (Pediatric Cancers, Brain and CNS and Head and Neck).

Bar chart: Japan Proton Therapy market size, 2024–2034, placeholder estimates. $84.8 Mn in 2024, $92.7 Mn in 2025 and $206.4 Mn in 2034, 9.3% CAGR.
Japan Proton Therapy market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Japan Proton Therapy Market Dynamics

Market Growth Drivers

Rising cancer cases, earlier detection, precision medicine and a strong pipeline of targeted and immune therapies are driving the proton Therapy market. Faster approvals and new combinations are improving survival.

Opportunity

Biomarker-led treatment, earlier lines of therapy and expansion into emerging markets offer strong growth for the proton Therapy market.

Market Restraints

High treatment costs, drug resistance, side effects and unequal access to cancer centres hold back the proton Therapy market, especially in low- and middle-income countries.

Competitive Landscape for Proton Therapy Market in Japan

The proton Therapy market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Proton Therapy Market in Japan

Proton Therapy in Japan: rules and payment

Medical devices are notified, certified or approved depending on their risk; the Pharmaceuticals and Medical Devices Agency (PMDA) reviews higher-risk devices for approval by the Ministry of Health, Labour and Welfare.⁠[1] Everyone is covered by public health insurance, and the Ministry of Health, Labour and Welfare sets the official price list for covered medicines (NHI prices).⁠[2]

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how proton Therapy products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Japan.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Proton Therapy right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Proton Therapy in context

Japan compared

  • Health spending per person: 3,638 US$ per person (2023). World: 1,317 US$ per person (2023). 4th highest of the 15 countries we cover in APAC.[1]
  • Doctors: 2.65 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 5th highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 30.0% of people (2025). World: 10.4% of people (2025). Highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 15 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 16 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Proton Therapy market in Japan?
Placeholder estimate: about $92.7 Mn in 2025, rising to about $206.4 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Proton Therapy market in Japan growing?
Placeholder estimate: about 9.3% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Proton Therapy market report cover?
The report splits the market by product (Proton Therapy Systems, Services), system (Single-Room Systems, Multi-Room Systems), cancer (Pediatric Cancers, Brain and CNS, Head and Neck, Prostate) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Proton Therapy market?
Key players include IBA (Ion Beam Applications), Varian (Siemens Healthineers), Hitachi Medical Systems, Mevion Medical Systems and Sumitomo Heavy Industries.
What is driving the Proton Therapy market?
Rising cancer cases, earlier detection, precision medicine and a strong pipeline of targeted and immune therapies are driving the proton Therapy market. Faster approvals and new combinations are improving survival.
Who regulates Proton Therapy in Japan?
Medical devices are notified, certified or approved depending on their risk; the Pharmaceuticals and Medical Devices Agency (PMDA) reviews higher-risk devices for approval by the Ministry of Health, Labour and Welfare. Source: Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.
How is healthcare paid for in Japan?
Everyone is covered by public health insurance, and the Ministry of Health, Labour and Welfare sets the official price list for covered medicines (NHI prices). Source: Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.
How much research is published on Proton Therapy?
PubMed lists 3,474 papers on Proton Therapy added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Japan

See all

Related on oncology

See the topic